An official State of Texas website.
The .gov means it’s official. State and federal government websites often end in .gov. Before sharing sensitive information, make sure you’re on an official government site.
The site is secure. The https:// ensures that you are connecting
Marilyn W. Edmunds, PhD, NP; Laurie Scudder, MS, NP
This Viewpoint offers a guide to the latest clinical and research articles of value to advanced practice nurses and other clinicians.
Pedersen CM, Rosendahl-Nielsen M, Hjermind J, Egerod I Intensive Crit Care Nurs. 2009;25:21-30
US Arm of IMPACT II Study Will Ascertain Reduction of Esophageal Thermal Injury During Cardiac RF Ablation Procedures
CHICAGO--(BUSINESS WIRE )--The US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to Attune Medical to evaluate the company’
The U.S. Food and Drug Administration (FDA) has approved a clinical trial to evaluate the safety and efficacy of a new type of ablation catheter for patients with ventricular tachycardia (VT) resistant to conventional anti-arrhythmic drugs or standard electrophysiology (EP) ablation procedures
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
By means of which those interested in participating in the following call are summoned, taking into account the purpose and the qualifying requirements that are listed below:OBJECT: Contract the purchase and sale of medical supplies for the IPSI MINGA.JUSTIFICATION: The IPSI MINGA must contract t
SUNNYVALE, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. BCDA , today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of BlueRock's cell therapy product candidates for the treatment of heart failure utilizing BioCardia's
IRVINE, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will host the Company’s
May 11, 2021 09:15 ET | Source: Verified Market Research Verified Market Research
Boonton, New Jersey, UNITED STATES
Childbirth is a messy process involving just about every bodily fluid imaginable. Some of these fluids are a cause for concern among a contingent of doctors across the U.S., and they allay that concern with urinary catheterization. It sounds like a scary, big deal, right? But what every pregna